特殊人群中的CBD和THC:药理动力学和药物相互作用
Lixuan Qian1, Jessica L Beers2, Klarissa D Jackson2
1Department of Chemistry, York College, City University of New York, Jamaica, NY 11451, USA.
Pharmaceutics
|April 27, 2024
概括
Cannabidiol (CBD) 和 delta-9-tetrahydrocannabinol (THC) 的使用正在增加,但它们在特殊人群中的药物相互作用 (DDI) 尚未研究. 需要更多的研究来确保在弱势群体中安全使用大麻素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物相互作用 药物相互作用
- 大麻素研究 研究 大麻素研究
背景情况:
- 大麻素的使用,特别是大麻 (CBD) 和三角-9-四大麻 (THC),已经显著增加.
- 这种增加需要对潜在的药物相互作用 (DDI) 进行彻底的了解,特别是在特殊人群中.
- 目前对这些群体中CBD和THCDDI的研究仍然有限,研究不足.
研究的目的:
- 审查关于CBD和THC药物相互作用的现有文献.
- 概述这些相互作用背后的机制.
- 讨论在特殊人群中对DDI的药理学考虑和建模方法.
主要方法:
- 关于CBD和THC与药物相互作用的已发表研究的综合文献综述.
- 在特殊人群中分析药理动力学数据和生理因素.
- 探索用于预测和理解DDI的建模技术.
主要成果:
- 关于CBD和THC在特殊人群中的药理动力学的研究有限.
- 在特殊人群中,CBD/THC与常用药物之间的潜在DDI需要进一步研究.
- 现有的临床试验已经探索了一些相互作用,但需要更广泛的范围.
结论:
- 有必要评估CBD/THC与特殊人群经常使用的药物之间的潜在DDI.
- 在特殊人群中,CBD和THC的药用动力学概况的特征很差.
- 建模方法为理解和预测这些复杂的药物相互作用提供了宝贵的工具.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
237
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
237
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
131
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
131
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
59
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
59
Factors Affecting Drug Biotransformation: Biological
146
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
146
Factors Affecting Drug Distribution: Physiological Barriers
197
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
197


